Coming soon. First inventory is in final QC.Coming soon
Compliance
You must be 21 or older. Agree to the following terms before accessing product information and pricing.
Research Use Policy Summary
For laboratory research use only. Not for human or veterinary consumption, diagnostic use, therapeutic use, or clinical use.
Metabolic Research
Accept the research disclaimer to view pricing and purchase options.
Product Usage Notice · This product is intended strictly for research and laboratory use only. It is designated for in vitro testing and experimental purposes. Any use involving human or animal consumption is prohibited by law. All information provided on this website is for educational purposes only. This product must only be handled by licensed, qualified professionals. It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such. Read full Research Use Policy →
Technical specifications
Tirzepatide is a 39-amino acid synthetic dual incretin receptor co-agonist (GIP/GLP-1) with a fatty acid conjugate for albumin binding, studied for incretin receptor pharmacology and metabolic pathway research.
Tirzepatide and Dual Incretin Receptor Pharmacology (SURMOUNT-1) New England Journal of Medicine Published pharmacology literature examining tirzepatide GIP and GLP-1 receptor mechanisms. Cited here for scientific context only; does not provide use guidance or product claims for this research compound.
View StudyTirzepatide and Metabolic Pathway Receptor Research (SURMOUNT-3) Nature Medicine Published pharmacology literature examining tirzepatide pharmacology and dual-receptor mechanisms. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.
View StudyReceptor Signaling of Tirzepatide in metabolic pathway research (SURPASS-1) The Lancet Published pharmacology literature. Cited for scientific context describing the dual GIP/GLP-1 receptor agonism mechanism under study in the literature. does not provide use guidance or product claims for this research compound.
View StudyTirzepatide and Dual Incretin Receptor Pharmacology in metabolic pathway research (SURMOUNT-1) New England Journal of Medicine Published pharmacology literature examining dual incretin receptor pharmacology. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.
View StudyThis compound is supplied strictly for in-vitro and preclinical research use only. Primary applications include the areas below.
Tool compound for investigating simultaneous GIP and GLP-1 receptor engagement and downstream intracellular signaling kinetics in cell-based models.
Used in preclinical metabolic research to characterize multi-receptor agonist mechanisms and structure-activity relationships in incretin signaling.
Lot records organize identity, purity, storage context, and supporting COA documentation for laboratory intake review.
Lot documentation reports 99%+ purity and identity verification by the listed analytical method.
Explore
5-Amino-1MQView details
Acetic AcidView details
ADAMAXView details
AOD-9604View details
Bacteriostatic WaterView details
BPC-157View details
BPC-157, TB-500 (Blend)View details
CJC-1295 DACView details
CJC-1295 No DACView details
DSIP (Delta Sleep-Inducing Peptide)View details
EpithalonView details
GHK-Cu (Copper Peptide)View details
Glow Blend (BPC-157, TB-500, GHK-Cu)View details
GlutathioneView details
HGH Fragment 176-191View details
IGF-1 LR3View details
IpamorelinView details
Ipamorelin, CJC-1295 No DAC (Blend)View details
Kisspeptin-10View details
Klow Blend (BPC-157, TB-500, GHK-Cu, KPV)View details
KPVView details
Melanotan IIView details
MOTS-CView details
NAD+View details
PinealonView details
PT-141 (Bremelanotide)View details
Retatrutide (GLP3-R)View details
SelankView details
SemaxView details
SermorelinView details
SLU-PP-332View details
SS-31 (Elamipretide)View details
TB-500 (Thymosin Beta-4)View details
TesamorelinView details
Thymosin Alpha-1View details